Cargando…
Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B
Prior to its total synthesis, a new vanadium coordination compound, called TSAG0101, was computationally designed to inhibit the enzyme protein tyrosine phosphatase 1B (PTP1B). The PTP1B acts as a negative regulator of insulin signaling by blocking the active site where phosphate hydrolysis of the i...
Autores principales: | Scior, Thomas, Guevara-García, José Antonio, Melendez, FJ, Abdallah, Hassan H, Do, Quoc-Tuan, Bernard, Philippe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948933/ https://www.ncbi.nlm.nih.gov/pubmed/20957214 |
Ejemplares similares
-
Why Antidiabetic Vanadium Complexes are Not in the Pipeline of “Big Pharma” Drug Research? A Critical Review
por: Scior, Thomas, et al.
Publicado: (2016) -
Insulin Mimetic Peroxo Complexes of Vanadium Containing Uracil or Cytosine as Ligand
por: Sarkar, Asit R., et al.
Publicado: (2000) -
Modulating testosterone pathway: a new strategy to tackle male skin aging?
por: Bernard, Philippe, et al.
Publicado: (2012) -
Are vanadium complexes druggable against the main protease M(pro) of SARS-CoV-2? – A computational approach
por: Scior, Thomas, et al.
Publicado: (2021) -
A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism
por: Juliana, Christine A., et al.
Publicado: (2023)